Azelastine Hydrochloride Spray, Metered
Product Images NDC 68788-8514

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 68788-8514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azelastine HCl Nasal Spray 01% (37c40f8d 269c 4df8 8ac7 Cbe78f4ca5c4 00)

Azelastine HCl Nasal Spray 01% (37c40f8d 269c 4df8 8ac7 Cbe78f4ca5c4 00)
Label for Azelastine HCl Nasal Spray 0.1%, a metered nasal spray by Preferred Pharmaceuticals Inc. The label includes dosing information delivering 137 mcg azelastine hydrochloride per spray, storage instructions, warnings, and bilingual (English and Spanish) directions for use. Manufactured by Aurobindo Pharma Limited. Package specifics such as lot number, batch, and expiration date are blank.*
FDA Label Image

Figure A (Azelastine Fig1)

Figure A (Azelastine Fig1)
Illustration showing components of a spray bottle unit for Azelastine Hydrochloride nasal spray. It labels the dust cover, spray pump unit with "shoulders," safety clip, and bottle, providing a visual guide to the parts of the metered nasal spray.*
FDA Label Image

Figure B (Azelastine Fig2)

Figure B (Azelastine Fig2)
Illustration showing a hand holding a nasal spray bottle labeled as Figure B. The image demonstrates the action of removing the spray head cap horizontally while keeping the bottle steady, indicating preparation of the metered nasal spray for use.*
FDA Label Image

Figure C (Azelastine Fig3)

Figure C (Azelastine Fig3)
An instructional diagram labeled Figure C showing a hand holding a nasal spray bottle. The illustration demonstrates pressing the pump to release the spray from the nozzle, with an arrow indicating downward pressure and spray droplets shown exiting the nozzle.*
FDA Label Image

Figure D (Azelastine Fig4)

Figure D (Azelastine Fig4)
An instructional illustration labeled Figure D showing a person using a metered nasal spray. The image depicts the spray bottle being inserted into one nostril while the person’s head is tilted slightly backward, demonstrating the correct technique for nasal administration.*
FDA Label Image

Figure E (Azelastine Fig5)

Figure E (Azelastine Fig5)
An instructional illustration labeled 'Figure E' showing a person demonstrating how to use a nasal spray. The person holds the spray bottle with one hand near the nose and uses the other hand to position the nose, indicating the proper method to administer the nasal spray.*
FDA Label Image

Figure F And Figure G (Azelastine Fig6)

Figure F And Figure G (Azelastine Fig6)
An instructional illustration showing hands using a metered nasal spray bottle. Figure F shows priming or shaking the spray bottle, and Figure G depicts spraying the medication away from the face, demonstrating proper use of the nasal spray.*
FDA Label Image

Chemical Structure (Azelastine Str)

Chemical Structure (Azelastine Str)
Chemical structure of azelastine hydrochloride showing its molecular arrangement with labeled functional groups and atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.